Syphilis Market Is Expected To Grow During the Forecast Period (2019-2032), DelveInsight

A detailed review of the historical and forecasted Syphilis market is included in the report, covering drug outreach in the 7MM countries. The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Syphilis market. An all-inclusive account of both the current and emerging therapies for Syphilis, along with the assessment of new therapies, will have an impact on the current treatment landscape.

Syphilis: An Overview
Syphilis is a sexually transmitted disease (STD) caused by the bacterium Treponema pallidum. Syphilis can cause serious health sequelae if not adequately treated. Syphilis is transmitted from person to person by direct contact with a syphilitic sore, known as a chancre. Chancres can occur on or around the external genitals, in the vagina, around the anus, in the rect#m, or in or around the mouth. Transmission of syphilis can occur during vaginal, anal, or oral s#x. In addition, pregnant women with syphilis can transmit the infection to their unborn child.

Discover more information about the report- https://www.delveinsight.com/sample-request/syphilis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Key highlights of the Syphilis Market Report
• In 2018, there were 115,045 reported new diagnoses of syphilis (all stages), compared to 38,739 estimated new diagnoses of HIV infection in 2017 and 583,405 cases of gonorrhea in 2018.
• According to the published literature, men are affected more frequently with primary or secondary syphilis than women.
• MSM accounted for 77.6% of all P&S syphilis cases among males in which sex of sex partner was known and 64.3% of P&S syphilis cases among men or women with information about the sex of sex partner. However, in recent years, the rate of P&S syphilis has been increasing among MSM as well as heterosexual men and women.

Syphilis Epidemiology Segmentation in the 7MM
• Total Syphilis Incident Cases
• Syphilis Gender-specific Incidence
• Syphilis Age-specific Incidence
• Syphilis Type-specific Incidence
• Syphilis Diagnosed and Treatable Cases

Syphilis Treatment Market
Syphilis can usually be treated with a short course of antibiotics. It's important to get it treated because syphilis won't normally go away on its own and it can cause serious problems if left untreated.
Antibiotics for syphilis:-
Syphilis that has lasted less than 2 years is usually treated with an injection of penicillin into buttocks, or a 10-14 day course of antibiotic tablets if the person can't have penicillin. Syphilis that has lasted more than 2 years is usually treated with 3 penicillin injections into buttocks given at weekly intervals, or a 28 day course of antibiotic tablets if the person can't have penicillin.

Syphilis Market Insights
Penicillin was established as an effective treatment for syphilis before the widespread use of randomized clinical trials. The treatment guidelines published by the CDC (see current CDC recommendations) are based largely on uncontrolled trials and expert opinion. Guidelines are based on staging, with later stages requiring longer courses of treatment due to the slower rate of bacterial replication.

Syphilis Market Forecast
The effectiveness of penicillin for the treatment of syphilis was well established through clinical experience even before the value of randomized controlled clinical trials was recognized. Therefore, nearly all recommendations for the treatment of syphilis are based not only on clinical trials and observational studies, but many decades of clinical experience.

Request a Sample Copy of the Report- https://www.delveinsight.com/sample-request/syphilis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Syphilis Market Growth
The factors that shall expedite the growth of the Syphilis market include increasing awareness about available treatments during the forecast period (2019-2030). Overall, the increasing Incidence, disease awareness, and promising emerging pipeline therapies will propel the market size forward during the forecast period. A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Syphilis. Overall, the rise in Syphilis population increased funding by governmental bodies, and vigorous R&D activities are further expected to propel the Syphilis market during the forecast period (2020-2030).

Syphilis Market Size
The market size shall grow during the forecast period owing to the launch of upcoming therapies. The market size is expected to increase at a significant CAGR during the study period. Anticipated research and development activities of pharmaceutical companies and academics for developing the therapies for Syphilis are expected to propel the growth of the market.

Syphilis Market Dynamics
The dynamics of the Syphilis market are anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, raising awareness of the disease, and incremental healthcare spending across the world.

Explore information about the report- https://www.delveinsight.com/report-store/syphilis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Key Insights
2. Syphilis Executive Summary
3. Competitive Intelligence Analysis for Syphilis
4. Syphilis: Market Overview at a Glance
5. Syphilis: Disease Background and Overview
6. Patient Journey
7. Syphilis Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Syphilis Unmet Needs
10. Key Endpoints of Syphilis Treatment
11. Syphilis Marketed Products
12. Syphilis Emerging Therapies
13. Syphilis: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview
17. KOL Views
18. Syphilis Market Drivers
19. Syphilis Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight

Get in touch with our Business Expert @ https://www.delveinsight.com/report-store/syphilis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Contact Us
Yash
info@delveinsight.com

About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

This release was published on openPR.